Short-term UV radiation linked to odds of juvenile myositis

Short-term UV radiation linked to odds of juvenile myositis
Short-term ultraviolet radiation exposure may contribute to the development of juvenile myositis, according to a study published in the July issue of Arthritis & Rheumatism.

(HealthDay)—Short-term ultraviolet radiation (UVR) exposure may contribute to the development of juvenile myositis, according to a study published in the July issue of Arthritis & Rheumatism.

Mona Shah, Ph.D., from the National Institutes of Health in Bethesda, Md., and colleagues examined the correlation between UVR exposure in the month prior to symptom onset and the prevalence of juvenile dermatomyositis (JDM) versus polymyositis (JPM) in 298 . The correlation between UVR exposure and myositis autoantibodies was evaluated among patients with JDM.

The researchers found that, in girls, the odds of JDM versus JPM increased per unit increase in the patients' highest UV index in the month before symptom onset (odds ratio [OR], 1.18; 95 percent confidence interval, 1.00 to 1.40). Increasing odds of anti-p155/140 autoantibodies were seen in correlation with average and highest UV indices, a finding that was strongest in white males (OR, 1.30 and 1.23, respectively). There was no correlation seen between the UV index and anti-MJ autoantibodies or patients without myositis autoantibodies. The average UV index was associated with increasing odds of JDM and anti-p155/140 autoantibodies and with decreasing odds of anti-MJ autoantibodies across U.S. geoclimatic regions.

"This study adds important information about the impact of UVR on autoimmune muscle disease," write the authors. "The association of UVR with JDM and with anti-p155/140 autoantibodies has implications for photoprotective prevention measures, as well as for research regarding the role of UVR in the pathogenesis of myositis in children."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

ACR: Most hospitalizations for gout are preventable

Nov 18, 2014

(HealthDay)—Most hospitalizations for a primary diagnosis of gout are preventable, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 14 to 19 in ...

TNF inhibitors may increase cancer risk in the eye

Nov 17, 2014

One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.